C12P 21 - Preparation of peptides or proteins

Patents for C12P 21 - Preparation of peptides or proteins (112,499)
12/2002
12/26/2002	US20020197676 Novel chromophores/fluorophores and methods for using the same
12/26/2002	US20020197675 Glial nerovus system modulator for use in the treatment of nervous system disorders and spine damage
12/26/2002	US20020197674 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/26/2002	US20020197672 Comparative ligand mapping from MHC positive cells
12/26/2002	US20020197671 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/26/2002	US20020197667 Polypeptide for use in the treatment of thrombosis and sepsis
12/26/2002	US20020197666 Human chordin-related proteins and polynucleotides encoding them
12/26/2002	US20020197655 Antigen and monoclonal antibody which recognizes the antigen
12/26/2002	US20020197615 Nucleotide sequences coding polypeptide for use as diagnostic tool
12/26/2002	US20020197612 Nucleotide sequences coding polypeptides for use in the treatment of thrombosis, arthritis and cell proliferation defects
12/26/2002	US20020197605 Novel Polynucleotides
12/26/2002	US20020197598 Two hybrid assay that detects hiv-1 reverse transcriptase dimerization
12/26/2002	US20020197277 Cell culture system for synthesis of infectious hepatitis C virus
12/26/2002	US20020197262 Photoimmunotherapies for cancer using photosensitizer immunoconjugates and combination therapies
12/26/2002	US20020197260 Molecular mimetics of unique neisseria meningitidis serogroup B epitopes
12/26/2002	US20020197256 Combination therapy
12/26/2002	US20020197255 Therapeutic application of chimeric and radiolabelled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
12/25/2002	CN1387578A Novel compound F-15078
12/25/2002	CN1387577A Process for producing product contg. antihypertensive tripeptides
12/25/2002	CN1387566A Cyclic depsipeptide synthases, genes thereof and mass production system of cyclic depsipeptide
12/25/2002	CN1387564A Lactobacillus helvetius producing antihypertensive di- and tripeptides
12/25/2002	CN1387539A Human monoclonal antibodies to prostate specific membrane antigen
12/25/2002	CN1386862A Process for preparing cicer protein polypeptide by enzyme method and its use
12/25/2002	CN1386849A Polypeptide-Ser/Thr kinase protein-51.37 and polynucleotide for coding it
12/25/2002	CN1386762A Polypeptide-human macroprotein-51.37 and polynucleotide for coding it
12/25/2002	CN1386761A Polypeptide-human reverse transcription associated protein-14.08 and polynucleotide for coding it
12/25/2002	CN1386760A Polypeptide-olfactory receptor-10.78 and polynucleotide for coding it
12/25/2002	CN1386759A Polypeptide-elastatinal-43.12 and polynucleotide for coding it
12/25/2002	CN1386758A Polypeptide-human reverse transcription associated protein-15.07 and polynucleotide for coding it
12/25/2002	CN1386757A Polypeptide-leukemia associated protein 29.81 and polynucleotide for coding it
12/25/2002	CN1386756A Polypeptide-polypeptide chain surface receptor-38.28 and polynucleotide for coding it
12/25/2002	CN1386755A Polypeptide-glucoprotein-11.22 and polynucleotide for coding it
12/25/2002	CN1386751A Polypeptide-Pre-mRNA splicing factor-59.40 and polynucleotide for coding it
12/25/2002	CN1386748A Polypeptide-ribosomal L3 protein-9.68 and polynucleotide for coding it
12/25/2002	CN1386747A Polypeptide-histone H4-10.01 and polynucleotide for coding it
12/25/2002	CN1386746A Polypeptide-thermal shock protein-10.67 and polynucleotide for coding it
12/24/2002	US6498243 Epimorphin antagonist and process for producing it
12/24/2002	US6498233 Nucleic acid transfer system
12/24/2002	US6498022 Isolated nucleic acid molecules encoding human carbonate transporter proteins, and uses thereof
12/24/2002	US6498020 Fusion proteins comprising coiled-coil structures derived of bovine IF1 ATPase inhibitor protein
12/24/2002	US6497881 Complex comprising streptavidin-protein a fusion protein having antibody and biotin binding sites, bound antibody specific for cell surface protein, which undergoes endocytosis after binding, bound biotinylated toxin, expressed in cell
12/24/2002	US6497879 Composition which comprises isolated mage-10 tumor rejection antigen precursor which is encoded by nucleic acid having specified nucleotide sequence
12/24/2002	US6497878 Systemically administering amount of anti-interleukin-8 antibody effective to treat cerebral infarction
12/24/2002	US6497871 Polypeptide having anti-viral and anti-proliferative activity
12/24/2002	CA2087261C Purification directed cloning of peptides
12/24/2002	CA2086264C Surface complexed lymphotoxin
12/24/2002	CA2070182C Chimeric immunoglobulin for cd4 receptors
12/24/2002	CA2065404C Assays and reagents for amyloid deposition
12/19/2002	WO2002101075A2 Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer
12/19/2002	WO2002101074A2 Nucleic acid constructs useful for glucose regulated production of human insulin in somatic cell lines
12/19/2002	WO2002101069A2 Ns4 nucleic acids and polypeptides and methods of use for the treatment of body weight disorders
12/19/2002	WO2002101058A1 Novel promoter
12/19/2002	WO2002101048A2 NEW POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNα-7 GENE
12/19/2002	WO2002101044A2 Brain expressed gene and protein associated with bipolar disorder
12/19/2002	WO2002101040A1 Human-type anti-blood coagulation factor viii antibody
12/19/2002	WO2002101039A1 Method of testing drug for treating or preventing diseases such as hyperlipemia
12/19/2002	WO2002101038A1 Method of constructing host and process for producing foreign protein
12/19/2002	WO2002101021A2 Purification of human serum albumin
12/19/2002	WO2002101019A2 Methods of culturing animal cells and polypeptide production in animal cells
12/19/2002	WO2002101013A2 A biological method for the production of alpha-methylene-gamma-butyrolactone and its intermediates
12/19/2002	WO2002101009A2 Structural and cytoskeleton-associated proteins
12/19/2002	WO2002101008A2 Intracellular signaling molecules
12/19/2002	WO2002101006A2 Production of proteins in plants
12/19/2002	WO2002101005A2 A g-protein coupled receptor and uses therefor
12/19/2002	WO2002100998A2 Method for generating diversity
12/19/2002	WO2002100876A1 Dock 3 tumor suppressor gene
12/19/2002	WO2002100348A2 Human monoclonal antibodies to epidermal growth factor receptor (egfr)
12/19/2002	WO2002100326A2 Photoimmunotherapies for cancer using photosensitizer immunoconjugates and combination therapies
12/19/2002	WO2002085937A3 Inflammation-specific peptides and the uses thereof
12/19/2002	WO2002081677A3 Improved gene expression
12/19/2002	WO2002070565A3 High-affinity antagonists of elr-cxc chemokines
12/19/2002	WO2002066603A3 Chemically defined medium for cultured mammalian cells
12/19/2002	WO2002062370A9 Stabilization of hypoallergenic, hyperdigestible previously reduced proteins
12/19/2002	WO2002024727A3 New inhibitors of iapp fibril formation and uses thereof
12/19/2002	WO2002012338A3 Screening method
12/19/2002	WO2002004665A3 Method with a wide range of applications, for identifying modulators of g-protein-coupled receptors
12/19/2002	WO2001077169A9 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides
12/19/2002	WO2001068859A9 Il-17 receptor like molecules and uses thereof
12/19/2002	US20020194641 PUFA polyketide synthase systems and uses thereof
12/19/2002	US20020194633 Novel low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis
12/19/2002	US20020193573 Methods for making antibody fragments and compositions resulting therefrom
12/19/2002	US20020193572 Generation of glycosylated antibody; obtain cell, incubate with vector expressing preferential antibody, transfected with a vector, propagate, express vector, recover antibody
12/19/2002	US20020193571 Wsx receptor agonist antibodies
12/19/2002	US20020193570 Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation
12/19/2002	US20020193564 Polypeptide for use in the treatment of muscular, huntington's and alzhemiers's diseases
12/19/2002	US20020193561 P53 protein variants and therapeutic uses thereof
12/19/2002	US20020193396 Sulfonamido ether substituted imidazoquinolines
12/19/2002	US20020193309 Contacting the sample or tissue with fibroblast growth factor 9 (FGF9) and allowing formation of receptor-ligand pairs; detecting presence of FGFR3-FGF9 pairs, a positive detection indicating presence of FGFR3 in the sample or tissue
12/19/2002	US20020193308 Recombinant protein and its use in therapy and diagnostics
12/19/2002	US20020193300 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/19/2002	US20020193299 For use as pharmaceuticals, diagnostics, biosensors and bioreactors
12/19/2002	US20020193293 Low oxygen affinity mutant hemoglobins
12/19/2002	US20020192822 Herpes simplex virus ICP4 is an inhibitor of apoptosis
12/19/2002	US20020192801 Human uridine diphosphate galactose-4-epimerase
12/19/2002	US20020192790 Polynucleotides for use in the treatment and diagnosis of cancer and autoimmune diseases
12/19/2002	US20020192789 Novel enterokinase cleavage sequences
12/19/2002	US20020192785 For use in therapeutics, diagnostics, and as research tools
12/19/2002	US20020192784 Nucleotide sequences coding polypeptide for use in the treatment of bone and connective tissue disorders
12/19/2002	US20020192765 Culturing water soluble yeast extract; obtain yeast, culture, incubate with peroxide, expose to spectrum analysis, purify yeast
12/19/2002	US20020192763 Compositions and methods for the therapy and diagnosis of prostate cancer

1 ... 623 624 625 626 627 628 629 630 631 632 633 634 635 636 637 638 639 640 641 642 643 ... 1125